Literature DB >> 8030754

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

M A Smith1, R K Kutty, P L Richey, S D Yan, D Stern, G J Chader, B Wiggert, R B Petersen, G Perry.   

Abstract

Heme oxygenase-1 is an important enzyme that degrades heme, a pro-oxidant, leading to the formation of antioxidant molecules. In this study we demonstrate by immunocytochemistry close association of heme oxygenase-1 with Alzheimer neurofibrillary pathology and with the neurofibrillary tangles found in progressive supranuclear palsy and subacute sclerosing panencephalitis. In Alzheimer's disease, using two different rabbit antisera against heme oxygenase-1 protein, we localized, using immunocytochemical methods, heme oxygenase-1 to neurofibrillary tangles, senile plaque neurites, granulovacuolar degeneration, and neuropil threads. Only light background staining was seen in young controls and sporadic lesion-related immunoreactivity in age-matched controls. The increase in heme oxygenase-1 protein in association with the neurofibrillary pathology of Alzheimer's disease and other diseases characterized by neurofibrillary tangles supports the notion that the generation of free radicals and oxidative stress plays a role in the pathogenesis of neurofibrillary pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030754      PMCID: PMC1887290     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible.

Authors:  M D Maines; G M Trakshel; R K Kutty
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

2.  Cloning and expression of cDNA for rat heme oxygenase.

Authors:  S Shibahara; R Müller; H Taguchi; T Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Authors:  M A Smith; S Taneda; P L Richey; S Miyata; S D Yan; D Stern; L M Sayre; V M Monnier; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

6.  Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea.

Authors:  D J Selkoe; Y Ihara; F J Salazar
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

7.  Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.

Authors:  E K Perry; J R Atack; R H Perry; J A Hardy; P R Dodd; J A Edwardson; G Blessed; B E Tomlinson; A F Fairbairn
Journal:  J Neurochem       Date:  1984-05       Impact factor: 5.372

8.  Elevated levels of heme oxygenase-1 activity and mRNA in peripheral blood adherent cells of acquired immunodeficiency syndrome patients.

Authors:  R D Levere; R Staudinger; G Loewy; A Kappas; S Shibahara; N G Abraham
Journal:  Am J Hematol       Date:  1993-05       Impact factor: 10.047

9.  Increased expression of heat-shock protein 27 kDa in Alzheimer disease: a preliminary study.

Authors:  K Renkawek; G J Bosman; M Gaestel
Journal:  Neuroreport       Date:  1993-10-25       Impact factor: 1.837

10.  Brain glutathione peroxidase in neurodegenerative disorders.

Authors:  S J Kish; C L Morito; O Hornykiewicz
Journal:  Neurochem Pathol       Date:  1986-02
View more
  79 in total

Review 1.  The role of cell cycle-mediated events in Alzheimer's disease.

Authors:  A K Raina; M J Monteiro; A McShea; M A Smith
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 2.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

3.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

Authors:  M A Smith; P L Harris; L M Sayre; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

4.  Widespread distribution of reticulon-3 in various neurodegenerative diseases.

Authors:  Jonathon E Heath; Sandra L Siedlak; Xiongwei Zhu; Hyoung-Gon Lee; Akanksha Thakur; Riqiang Yan; George Perry; Mark A Smith; Rudy J Castellani
Journal:  Neuropathology       Date:  2010-12       Impact factor: 1.906

5.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

Review 6.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

Review 7.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

8.  Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.

Authors:  Paula I Moreira; Lawrence M Sayre; Xiongwei Zhu; Akihiko Nunomura; Mark A Smith; George Perry
Journal:  Methods Mol Biol       Date:  2010

Review 9.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

Review 10.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.